MEDIPOST Co., Ltd. (KOSDAQ: 078160)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,340
+370 (3.09%)
Dec 20, 2024, 12:37 PM KST

MEDIPOST Company Description

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally.

The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food.

It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis.

In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia.

Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy.

Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services.

The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.

MEDIPOST Co., Ltd.
Country South Korea
Founded 2000
Industry Biological Products, Except Diagnostic Substances
Employees 308

Contact Details

Address:
21, Daewangpangyo-ro
Seongnam-si
South Korea
Phone 82 2 3465 6677
Website medi-post.co.kr

Stock Details

Ticker Symbol 078160
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2836